120 related articles for article (PubMed ID: 28349581)
1. TCF1 deficiency ameliorates autoimmune lymphoproliferative syndrome (ALPS)-like phenotypes of lpr/lpr mice.
Xu X; Yu B; Cai W; Huang Z
Scand J Immunol; 2017 Jun; 85(6):406-416. PubMed ID: 28349581
[TBL] [Abstract][Full Text] [Related]
2. Stabilized
Xu X; Huang J; Zhao M; Chen H; Mo J; Zhou X; Su Q; Yu B; Huang Z
J Immunol Res; 2017; 2017():3469108. PubMed ID: 29250557
[TBL] [Abstract][Full Text] [Related]
3. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
4. Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice.
Corneth OBJ; Schaper F; Luk F; Asmawidjaja PS; Mus AMC; Horst G; Heeringa P; Hendriks RW; Westra J; Lubberts E
Sci Rep; 2019 Mar; 9(1):4032. PubMed ID: 30858513
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
[TBL] [Abstract][Full Text] [Related]
6. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
7. Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS).
Yokoyama S; Perera PY; Terawaki S; Watanabe N; Kaminuma O; Waldmann TA; Hiroi T; Perera LP
J Clin Immunol; 2015 Oct; 35(7):661-7. PubMed ID: 26453583
[TBL] [Abstract][Full Text] [Related]
8. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
[TBL] [Abstract][Full Text] [Related]
9. IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes.
Boggio E; Clemente N; Mondino A; Cappellano G; Orilieri E; Gigliotti CL; Toth E; Ramenghi U; Dianzani U; Chiocchetti A
Blood; 2014 Feb; 123(8):1178-86. PubMed ID: 24363402
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 deficiency improves autoimmune nephritis caused by the fas mutation lpr.
Morito N; Yoh K; Hirayama A; Itoh K; Nose M; Koyama A; Yamamoto M; Takahashi S
Kidney Int; 2004 May; 65(5):1703-13. PubMed ID: 15086909
[TBL] [Abstract][Full Text] [Related]
11. FcRγ promotes T cell apoptosis in Fas-deficient mice.
Juvet SC; Thomson CW; Kim EY; Joe B; Adeyi O; Zhang L
J Autoimmun; 2013 May; 42():80-93. PubMed ID: 23313147
[TBL] [Abstract][Full Text] [Related]
12. miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslpr/lpr Mice.
Xin Q; Li J; Dang J; Bian X; Shan S; Yuan J; Qian Y; Liu Z; Liu G; Yuan Q; Liu N; Ma X; Gao F; Gong Y; Liu Q
J Immunol; 2015 Jun; 194(11):5437-45. PubMed ID: 25911753
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice.
Giudice ED; Ciaramella A; Balestro N; Neumann D; Romano PG; Cesaroni MP; Maurizi G; Ruggiero P; Boraschi D; Bossù P
Eur Cytokine Netw; 2001; 12(3):510-7. PubMed ID: 11566632
[TBL] [Abstract][Full Text] [Related]
14. Bcl-3 inhibits lupus-like phenotypes in BL6/lpr mice.
Tang W; Wang H; Tian R; Saret S; Cheon H; Claudio E; Siebenlist U
Eur J Immunol; 2021 Jan; 51(1):197-205. PubMed ID: 32652549
[TBL] [Abstract][Full Text] [Related]
15. Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
Rao VK; Dowdell KC; Dale JK; Dugan F; Pesnicak L; Bi LL; Hoffmann V; Penzak S; Avila NA; Fleisher TA; Puck JM; Straus SE
Am J Hematol; 2007 Dec; 82(12):1049-55. PubMed ID: 17674358
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS mutation (ALPS-FAS).
Marega LF; Teocchi MA; Dos Santos Vilela MM
Clin Exp Immunol; 2016 Aug; 185(2):148-53. PubMed ID: 27060458
[TBL] [Abstract][Full Text] [Related]
17. CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production.
Shi L; Bian Z; Chen CX; Guo YN; Lv Z; Zeng C; Liu Z; Zen K; Liu Y
J Pathol; 2015 Nov; 237(3):285-95. PubMed ID: 26095930
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
20. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
